Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
Details for Australian Patent Application No. 2004268024 (hide)
International Classifications
Event Publications
16 March 2006 PCT application entered the National Phase
PCT publication WO2005/020920 Priority application(s): WO2005/020920
12 July 2007 Application Accepted
Published as AU-B-2004268024
8 November 2007 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
4 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004268031-Fusion polypeptides, and use thereof in antivascular tumor therapy
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser